Press Releases

H.I.G. Capital Completes Acquisition of Taconic Biosciences

H.I.G. Capital Completes Acquisition of Taconic Biosciences

Boston, MA - February 7, 2019 - H.I.G. Capital ("H.I.G."), a leading global private equity investment firm with $30 billion of equity capital under management, is pleased to announce that one of its affiliates has partnered with the management team of Taconic Biosciences, Inc., ("Taconic" or the "Company") to support the Company's growth as a leading global provider of research models and services to the pharmaceutical, biotechnology,...  Read More

Nancy J. Sandy Appointed Chief Executive Officer of Taconic Biosciences

Nancy J. Sandy Appointed Chief Executive Officer of Taconic Biosciences

Rensselaer, NY — January 31, 2019 - Taconic Biosciences' Board of Directors has selected Nancy J. Sandy to succeed Dr. Robert J. Rosenthal as Chief Executive Officer (CEO). Effective January 14, Ms. Sandy took the company's top leadership position. Dr. Rosenthal, who held the position for four and a half years, continues his association with Taconic, leading external growth initiatives as Chief Innovation Officer and holds positions...  Read More

Taconic Biosciences' Animals Complete Most Recent Mission to the International Space Station

Taconic Biosciences' Animals Complete Most Recent Mission to the International Space Station

Rensselaer, NY — January 17, 2019 - Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces the completion of a recent mission to the International Space Station. This project represents a collaboration between the International Space Station (ISS) National Lab, National Aeronautics and Space Administration (NASA), Bioserve Space Technologies with support from the Leidos Corporation, and Taconic. Taconic has participated in several spaceflight...  Read More

Taconic Biosciences Becomes the First Animal Model Provider on General Services Administration Contract Schedule

Taconic Biosciences Becomes the First Animal Model Provider on General Services Administration Contract Schedule

Rensselaer, NY — September 20, 2018 - Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces a new relationship with Government Scientific Source (GSS). GSS is a leading dedicated distributor of laboratory equipment to federal, state, and local governments on contract with the GSA (General Services Administration). By having Taconic's products available via GSS, they can now be accessed by all federal agencies,...  Read More

Taconic Biosciences Partners with Science Exchange to Offer Online Access to its Products and Services

Taconic Biosciences Partners with Science Exchange to Offer Online Access to its Products and Services

Palo Alto, CA — (BUSINESS WIRE) — August 21, 2018 - Science Exchange, the leading marketplace for outsourced R&D™, announced today a collaboration with Taconic Biosciences, one of the world's foremost providers of genetically engineered rodent models and services, to offer on-demand access to Taconic's entire portfolio of products and services to researchers worldwide. Founded in 1952, Taconic is one of the most experienced rodent model design...  Read More

Taconic Biosciences and Cyagen Biosciences Announce Strategic Partnership

Taconic Biosciences and Cyagen Biosciences Announce Strategic Partnership

Rensselaer, NY — July 18, 2018 - Taconic Biosciences and Cyagen Biosciences, global leaders in the generation of custom genetically engineered rodent models and associated services, announced a strategic partnership. Under the agreement terms, the two companies will combine resources to provide the global scientific community with access to premium custom model design and generation services backed by comprehensive capabilities and cutting-edge, fully-licensed technologies. Custom animal models...  Read More

Taconic Biosciences Launches European Production of Diet Induced Obesity Model

Taconic Biosciences Launches European Production of Diet Induced Obesity Model

Rensselaer, NY — June 12, 2018 - Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, has launched local production of the Taconic diet induced obesity (DIO) model in Europe. DIO mice are used to study metabolic disease and obesity because they exhibit elevated glucose, insulin, cholesterol, leptin, and corticosterone, thus mimicking many aspects and complications of human metabolic disease. The Diet...  Read More

Scientist.com and Taconic Biosciences Offer Online Access to Next Generation Easi-CRISPR Technology

Scientist.com and Taconic Biosciences Offer Online Access to Next Generation Easi-CRISPR Technology

Researchers can now access Taconic Easi-CRISPR rodent models on the Scientist.com online marketplace San Diego, CA — May 21, 2018 - Scientist.com, the life science industry's leading online marketplace for outsourced research, announced today that it has partnered with Taconic Biosciences, a global leader in providing genetically engineered rodent model and service solutions. Pharmaceutical and biotech users of the Scientist.com marketplace can now purchase rodent models generated...  Read More

Taconic Biosciences Licenses Easi-CRISPR Technology from the University of Nebraska

Taconic Biosciences Licenses Easi-CRISPR Technology from the University of Nebraska

Rensselaer, NY — April 20, 2018 - Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, has been granted a license to the Easi-CRISPR technology from the University of Nebraska. Easi-CRISPR was developed in the laboratories of Drs. Masato Ohtsuka (Tokai University in Japan), and Channabasavaiah Gurumurthy (University of Nebraska). The terms of the agreement include a world-wide, non-exclusive license to the...  Read More

Taconic Biosciences Launches New Inflammatory Bowel Disease Models

Taconic Biosciences Launches New Inflammatory Bowel Disease Models

Rensselaer, NY — April 19, 2018 - Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, announces the launch of several new inflammatory bowel disease (IBD) animal models. As a fully-licensed provider of CRISPR/Cas9 gene editing technology, Taconic scientists knocked out the mouse Il10 gene to generate a spontaneous colitis mouse models. The new knockout models were created on Taconic's B6 (C57BL/6NTac)...  Read More

Close

Welcome! Tell us a little about yourself